O02 The JAK1-selective inhibitor filgotinib reverses the disease-associated transcriptional profile in the blood of patients with active rheumatoid arthritis. (12th April 2019) - Taylor, Peter; Downie, Bryan; Zhuo, Luting; Gindin, Yevgeniy; Tarrant, Jacqueline; Galien, René; Liu, Jinfeng; Mirza, Amer M